A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufacturers Under Fasted Conditions in Healthy Adult Subjects
Clinical trial NCT03517930 · COMPLETED
Trial details
- NCT number
- NCT03517930
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-17
- Primary completion
- 2018-07-20
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.